CD274 and breast carcinoma: Metformin also decreases PD-L1 levels through inducing abnormal PD-L1 glycosylation with Man9GlcNAc2, a rare glycan structure, which results in its degradation in the endoplasmic reticulum in breast cancer cells [155–157], see Figure 2.